EP2197448A4 - Dosing regimen - Google Patents

Dosing regimen

Info

Publication number: EP2197448A4
Authority: EP; European Patent Office
Prior art keywords: dosing regimen; regimen; dosing
Prior art date: 2007-09-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08830097A

Other languages

German (de)

French (fr)

Other versions

EP2197448A1 (en

Inventor

Gary Liversidge

Scott Jenkins

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Elan Pharma International Ltd

Original Assignee

Elan Pharma International Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-12

Filing date

2008-09-12

Publication date

2010-11-17

2008-09-12 Application filed by Elan Pharma International Ltd filed Critical Elan Pharma International Ltd

2010-06-23 Publication of EP2197448A1 publication Critical patent/EP2197448A1/en

2010-11-17 Publication of EP2197448A4 publication Critical patent/EP2197448A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/04—Arrangements for time indication or reminder for taking medicine, e.g. programmed dispensers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP08830097A 2007-09-12 2008-09-12 Dosing regimen Withdrawn EP2197448A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US97188207P	2007-09-12	2007-09-12
PCT/US2008/076189 WO2009036287A1 (en)	2007-09-12	2008-09-12	Dosing regimen

Publications (2)

Publication Number	Publication Date
EP2197448A1 EP2197448A1 (en)	2010-06-23
EP2197448A4 true EP2197448A4 (en)	2010-11-17

Family

ID=40452511

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08830097A Withdrawn EP2197448A4 (en)	2007-09-12	2008-09-12	Dosing regimen

Country Status (4)

Country	Link
EP (1)	EP2197448A4 (en)
JP (1)	JP2010539184A (en)
CA (1)	CA2697189A1 (en)
WO (1)	WO2009036287A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0979635A2 (en)	1998-08-12	2000-02-16	Origin Medsystems, Inc.	Tissue dissector apparatus
US10179130B2 (en)	1999-10-29	2019-01-15	Purdue Pharma L.P.	Controlled release hydrocodone formulations
EP2295043A1 (en)	1999-10-29	2011-03-16	Euro-Celtique S.A.	Controlled release hydrocodone formulations
US6733783B2 (en)	2000-10-30	2004-05-11	Euro-Celtique S.A.	Controlled release hydrocodone formulations
US6558313B1 (en)	2000-11-17	2003-05-06	Embro Corporation	Vein harvesting system and method
US9149472B2 (en)	2004-08-31	2015-10-06	Jack William Schultz	Controlled release compositions for treatment of cognitive, emotional and mental ailments and disorders
US9770230B2 (en)	2006-06-01	2017-09-26	Maquet Cardiovascular Llc	Endoscopic vessel harvesting system components
US20140161879A1 (en) *	2012-07-31	2014-06-12	Zogenix, Inc.	Treating pain in patients with hepatic impairment
US10322120B2 (en)	2012-07-31	2019-06-18	Persion Pharmaceuticals Llc	Treating pain in patients with hepatic impairment
AR094117A1 (en) *	2012-12-20	2015-07-08	Sanofi Aventis Deutschland	PACKAGING ASSEMBLY FOR DRUG ADMINISTRATION DEVICES
CA2928899C (en) *	2013-11-04	2021-02-16	Jack William SCHULTZ	Treatment of cognitive, emotional and mental ailments and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6673367B1 (en) *	1998-12-17	2004-01-06	Euro-Celtique, S.A.	Controlled/modified release oral methylphenidate formulations
US7674776B2 (en) *	1999-06-14	2010-03-09	Vivus, Inc.	Combination therapy for effecting weight loss and treating obesity
WO2003026628A2 (en) *	2001-09-28	2003-04-03	Mcneil-Ppc, Inc.	Composite dosage forms having an inlaid portion
GB0201367D0 (en) *	2002-01-22	2002-03-13	Ml Lab Plc	Composition
WO2005030181A1 (en) *	2003-09-26	2005-04-07	Alza Corporation	Controlled release formulations of opioid and nonopioid analgesics
US7188738B2 (en) *	2004-03-18	2007-03-13	Customer Advantage Llc	Medication minder
AU2005269981A1 (en) *	2004-07-02	2006-02-09	Bonck, John A	Tablet for pulsed delivery
US9161918B2 (en) *	2005-05-02	2015-10-20	Adare Pharmaceuticals, Inc.	Timed, pulsatile release systems

2008
- 2008-09-12 EP EP08830097A patent/EP2197448A4/en not_active Withdrawn
- 2008-09-12 CA CA2697189A patent/CA2697189A1/en not_active Abandoned
- 2008-09-12 JP JP2010525030A patent/JP2010539184A/en active Pending
- 2008-09-12 WO PCT/US2008/076189 patent/WO2009036287A1/en active Application Filing

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Famvir 500 mg Filmtabletten", 29 January 2001 (2001-01-29), XP002601168, Retrieved from the Internet <URL:http://www.pharmazie.com/graphic/A/09/1-21509.pdf> [retrieved on 20100916] *
ANONYMOUS: "Provigil", 11 September 2007 (2007-09-11), XP002601171, Retrieved from the Internet <URL:http://www.rxlist.com/provigil-drug.htm> [retrieved on 20100917] *
ANONYMOUS: "Rote Liste 2004", 2004, ECV EDITIO CANTOR VERLAG, Aulendorf, pages: 05-027, XP002601170 *
AVGERINOS A. ET AL.: "Pharmacokinetics of Nifedipine Derived from New Retard Tablet Formulation", EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, vol. 15, no. 4, 1990, pages 273 - 278, XP009138838 *
LEE DANIEL K C ET AL: "Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine mono phosphate challenge in persistent allergic rhinitis", BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. 57, no. 6, June 2004 (2004-06-01), pages 714 - 719, XP002601169, ISSN: 0306-5251 *
See also references of WO2009036287A1 *

Also Published As

Publication number	Publication date
WO2009036287A1 (en)	2009-03-19
JP2010539184A (en)	2010-12-16
CA2697189A1 (en)	2009-03-19
EP2197448A1 (en)	2010-06-23

Publication	Publication Date	Title
IL209370A0 (en)	2011-01-31	Dosing regimen
GB2451284B (en)	2012-10-17	Flowmeter
AU318967S (en)	2008-04-21	Packaging
AU320394S (en)	2008-07-24	Packaging
AU315662S (en)	2007-08-14	Package
EP2197448A4 (en)	2010-11-17	Dosing regimen
GB0710229D0 (en)	2007-07-11	Detergent dosing device
ZA201008885B (en)	2012-05-30	Telaprevir dosing regimen
GB0710230D0 (en)	2007-07-11	Detergent dosing device
PL2291107T3 (en)	2017-04-28	Dosing device
GB0715606D0 (en)	2007-09-19	Packaging
GB0721439D0 (en)	2007-12-12	Packaging
PL2342060T3 (en)	2012-12-31	Dosing device
IL213730A0 (en)	2011-07-31	Dosing device
GB2454144B (en)	2011-09-21	Dosing device
AU316596S (en)	2007-10-23	Packaging
PL1970496T3 (en)	2013-12-31	Dosing arrangement
GB0720002D0 (en)	2007-11-21	Packaging
GB0717987D0 (en)	2007-10-24	Packaging
GB0704321D0 (en)	2007-04-11	Packaging
GB2446586B (en)	2011-09-28	Packaging
PL383266A1 (en)	2009-03-16	Dosing unit
PL384667A1 (en)	2009-09-14	Dosing unit
GB0804860D0 (en)	2008-04-16	Dosing fill
PL379955A1 (en)	2007-12-24	Dosing unit

Legal Events

Date	Code	Title	Description
2010-05-21	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2010-06-23	17P	Request for examination filed	Effective date: 20100329
2010-06-23	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2010-06-23	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2010-11-17	A4	Supplementary search report drawn up and despatched	Effective date: 20101015
2010-12-22	DAX	Request for extension of the european patent (deleted)
2012-09-12	17Q	First examination report despatched	Effective date: 20120813
2013-05-17	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-06-19	18D	Application deemed to be withdrawn	Effective date: 20130103